Smart Health

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Merck, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development

Responds to global demand for biosafety testing for drug development and commercialization
Expansion creates nearly 500 new jobs in Glasgow and Stirling
Company’s investment to boost global testing capacity now tops € 350 million since mid-2022

Food Industry: Biodiversity Rising on Sustainability Agenda

Biodiversity is rising on the sustainability agenda. Ecovia Intelligence predicts more food companies to add biodiversity and nature-positive production into their sustainability plans, whilst new eco-labels are expected to be introduced.

3M Health Information Systems collaborates with AWS to accelerate AI innovation in clinical documentation

3M Health Information Systems (HIS) announces a collaboration with Amazon Web Services (AWS) to accelerate the innovation and advancement of 3M M*Modal ambient intelligence.

hubergroup India expands its support for rural healthcare

A joint project named “Fartu Davakhanu” with Rotary Vapi Riverside

Lettuce Takes up Toxic Additives From Tyre Wear

Chemicals from tyre wear could get into our vegetables via sewage sludge and waste water

BASF Pharma Solutions excipient accepted into FDA Pilot Program for novel excipients

U.S. Food and Drug Administration accepts Soluplus® branded excipient in its program to evaluate safety and acceptability of excipients for use in clinical trials, independent from a specific New Drug Application.

Excipients (inactive ingredients) such as the Soluplus® branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients

New mask study shows that method of hand drying can impact airborne spread of viruses

Virus load significantly higher with jet air dryer use than with paper towels

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Merck has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up
Allows Merck to offer full range of bioreactors, from 2ml to 2000L
Adds to company’s expertise in monoclonal antibody (mAb) process development

Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity

Merck invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA.

hubergroup India supports rural areas with medical vans

hubergroup India launched a healthcare initiative for rural areas in the Indian state of Gujarat, collaborating with Rotary Vapi Riverside. As part of this engagement, the ink and speciality chemicals producer hubergroup has sponsored two medical vans equipped with doctors, nurses, and basic medical equipment. These vans will be available in 16 remote villages every week for on-site medical check-ups and examinations. Rotary Vapi Riverside has extensive experience working in the local regions and supports this project with its know-how.

World Economic Forum marks World Mental Health Day

To mark this year’s World Mental Health Day, Shyam Bishen - Head of Health and Healthcare at the World Economic Forum - calls for stakeholders from the public and private sectors to come together and realise the vision of this year's World Mental Health Day to "Make mental health & well-being for all a global priority."